RENASCIENCE CO., LTD.
8Patents
7Active
8Granted
40Portfolio score
Filing activity: Sep 29, 2004 → Jul 22, 2020 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7417052B2 | Phenylene derivative having tetrazole ring or thiazolidinedione ring | Chemistry; Metallurgy | 1 | Expired |
| US11253519B2 | Composition used to improve symptoms of autism spectrum disorder, and method using same for improving symptoms of autism spectrum disorder | Human Necessities | 0 | Active |
| US8809329B2 | Detection and treatment of schizophrenia | Physics | 0 | Active |
| US8785473B2 | Plasminogen activator inhibitor-1 inhibitor | Chemistry; Metallurgy | 0 | Active |
| US8415479B2 | Inhibitor of plasminogen activator inhibitor-1 | Chemistry; Metallurgy | 0 | Active |
| US10092537B2 | Use for PAI-1 inhibitor | Human Necessities | 0 | Active |
| US11564924B2 | Pharmaceutical composition formed by combining pyridoxamine compound and thiamine compound | Human Necessities | 0 | Active |
| US7951806B2 | Plasminogen activator inhibitor-1 inhibitor | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.